Website Preloader
Website Preloader
September 29, 2023

Hackers Target LastPass, New Talk Back Feature In ChatGPT, and More

This Week In Tech, we talk about LastPass Phishing Emails, ChatGPT's New Talk Feature and the First Human Clinical Trial of Neuralink.
Written By: AlphaKOR

Photo Credit: Flickr

Hackers Target LastPass Users with Phishing Emails

The campaign aimed at stealing your data began about two weeks ago. As stated by LastPass, the campaign is global in scope and targets a variety of sectors, including 87 of their own employees. Some additional steps to consider when receiving such emails are to always verify senders email before clicking on any links. In this case the email appears to come from “[email protected]” which when clicked will take you to a fake URL “”. You can also hover your cursor over any link to see the actual URL before clicking. If the URL doesn’t match the official website of the organization, DO NOT click on it. Phishing attempts can evolve and become more sophisticated, so staying informed and vigilant is crucial in protecting your online security and personal information.

Read More: PCMag

Photo Credit: Unsplash

OpenAI Gives ChatGPT New Features to Talk Back

ChatGPT to Add Voice and Image Capabilities to the AI

For paid subscribers of ChatGPT’s Plus and Enterprise services, the new features will be be rolled out in the app over the next two weeks. OpenAI’s new voice and image features have similarities to Amazon’s Alexa voice assistant or Apple’s Siri. The new features will allow the Chatbot to tell a story out loud in a human-like voice and can also answer live questions about the story. The creator also mentioned that users will be able to take a photo while travelling and have the capabilities of having a live conservation about interesting facts of the photo with the AI.

Read More: TechXplore

The first Neuralink clinic

Photo Credit: Flickr

First Human Clinical Trial of Neuralink Opens Up

Elon Musk has been working on Neuralink’s goal for over 5 years

Elon Musk’s biotechnology startup Neuralink has made progress in its efforts to conduct human clinical trials for its brain-computer interface technology. The PRIME (Precise Robotically Implanted Brain-Computer Interface) Study aims to evaluate the safety and functionality of the implant in patients with paralysis. Patients in the trial will receive a chip surgically placed in the part of the brain that controls the intention to move. The chip installed by the robot will then record and send brain signals to an app, with the initial goal of “giving people the ability to control a cursor or computer keyboard with just their thoughts”.

Read More: CNN